23338131|t|Polydipsia-hyponatraemia syndrome : epidemiology, clinical features and treatment.
23338131|a|The polydipsia-hyponatraemia syndrome (PHS) occurs in about 5 to 10% of institutionalised, chronically psychotic patients, 80% of whom have schizophrenia. Major clinical features are polydipsia and dilutional hyponatraemia. Complications of PHS include delirium, generalised seizures, coma and death.Nonpharmacological interventions are fluid restriction, diurnal bodyweight monitoring, behavioural approaches, and supplemental oral sodium chloride administration. These interventions require an experienced and dedicated multidisciplinary staff.A number of pharmacological treatments have been assessed for PHS including the combination of lithium and phenytoin, demeclocycline, propranolol, ACE inhibitors, selective serotonin (5-hydroxytryptamine; 5-HT) reuptake inhibitors, typical antipsychotic drugs, clozapine and risperidone. Of these agents, the most promising are the combination of lithium and phenytoin, and clozapine.Integrated treatment requires a highly informed multidisciplinary staff, meticulous monitoring of diurnal weight gain and serum sodium level, and careful record keeping. Acute interventions of observation by trained staff, fluid restriction, water-free areas and supplemental sodium chloride administration are based on diurnal weight gain employing a monthly weight chart and a base weight method. Intravenous hypertonic saline is used briefly and administered in a highly controlled manner when patients with PHS present with generalised seizures and coma. Long term strategies include behavioural interventions and the combination of lithium and phenytoin, and clozapine.
23338131	0	33	Polydipsia-hyponatraemia syndrome	Disease	MESH:D059606
23338131	87	120	polydipsia-hyponatraemia syndrome	Disease	MESH:D059606
23338131	122	125	PHS	Disease	MESH:D059606
23338131	186	195	psychotic	Disease	MESH:D011618
23338131	196	204	patients	Species	9606
23338131	223	236	schizophrenia	Disease	MESH:D012559
23338131	266	276	polydipsia	Disease	MESH:D059606
23338131	292	305	hyponatraemia	Disease	
23338131	324	327	PHS	Disease	MESH:D059606
23338131	336	344	delirium	Disease	MESH:D003693
23338131	358	366	seizures	Disease	MESH:D012640
23338131	368	372	coma	Disease	MESH:D003128
23338131	377	382	death	Disease	MESH:D003643
23338131	516	531	sodium chloride	Chemical	MESH:D012965
23338131	691	694	PHS	Disease	MESH:D059606
23338131	724	731	lithium	Chemical	MESH:D008094
23338131	736	745	phenytoin	Chemical	MESH:D010672
23338131	747	761	demeclocycline	Chemical	MESH:D003707
23338131	763	774	propranolol	Chemical	MESH:D011433
23338131	792	811	selective serotonin	Chemical	-
23338131	813	832	5-hydroxytryptamine	Chemical	MESH:D012701
23338131	834	838	5-HT	Chemical	MESH:D012701
23338131	890	899	clozapine	Chemical	MESH:D003024
23338131	904	915	risperidone	Chemical	MESH:D018967
23338131	976	983	lithium	Chemical	MESH:D008094
23338131	988	997	phenytoin	Chemical	MESH:D010672
23338131	1003	1012	clozapine	Chemical	MESH:D003024
23338131	1119	1130	weight gain	Disease	MESH:D015430
23338131	1141	1147	sodium	Chemical	MESH:D012964
23338131	1289	1304	sodium chloride	Chemical	MESH:D012965
23338131	1341	1352	weight gain	Disease	MESH:D015430
23338131	1424	1441	hypertonic saline	Chemical	MESH:D012965
23338131	1510	1518	patients	Species	9606
23338131	1524	1527	PHS	Disease	MESH:D059606
23338131	1553	1561	seizures	Disease	MESH:D012640
23338131	1566	1570	coma	Disease	MESH:D003128
23338131	1650	1657	lithium	Chemical	MESH:D008094
23338131	1662	1671	phenytoin	Chemical	MESH:D010672
23338131	1677	1686	clozapine	Chemical	MESH:D003024
23338131	Negative_Correlation	MESH:D012965	MESH:D015430
23338131	Comparison	MESH:D003024	MESH:D008094
23338131	Negative_Correlation	MESH:D011433	MESH:D059606
23338131	Comparison	MESH:D003024	MESH:D010672
23338131	Negative_Correlation	MESH:D012965	MESH:D012640
23338131	Cotreatment	MESH:D008094	MESH:D010672
23338131	Negative_Correlation	MESH:D012965	MESH:D059606
23338131	Negative_Correlation	MESH:D012965	MESH:D003128
23338131	Negative_Correlation	MESH:D008094	MESH:D059606
23338131	Negative_Correlation	MESH:D003024	MESH:D059606
23338131	Negative_Correlation	MESH:D010672	MESH:D059606
23338131	Negative_Correlation	MESH:D018967	MESH:D059606
23338131	Negative_Correlation	MESH:D003707	MESH:D059606

